Canino Glorisa, Vila Doryliz, Cabana Michael, Quiñones Amarilis, Otero Mirla, Acosta Edna, Pabón-Cruz Karen, Colón Frances M, Rand Cynthia
University of Puerto Rico, Medical Sciences Campus, Behavioral Sciences Research Institute, San Juan, Puerto Rico.
Pediatr Allergy Immunol Pulmonol. 2010 Nov 1;23(3):169-174. doi: 10.1089/ped.2010.0023.
There are substantial disparities in dispensing patterns of long term control medications for asthma among children in Puerto Rico with public insurance as compared to those with private insurance. Public health insurance policy in Puerto Rico includes the cost of medications in the capitation paid to the primary care physicians and clinics. METHODS: Survey questionnaires were mailed to all pediatricians enrolled in the Puerto Rico College of Physicians (n=798) in addition to some pediatricians not enrolled in the College (n=25) for a total of 823 pediatricians. Of these, 722 were eligible pediatricians with 458 responding to the survey for a response rate of 63.4%. RESULTS: Most of the respondents expressed being moderately to very familiar with the National Asthma Education and Prevention Program (NAEPP) guidelines (71.7%) and with the NAEPP recommendations for controller asthma medication use (73.5%). Inadequate capitation to cover asthma medication (86.2%) and lack of adequate health insurance coverage of the patient (83.2%) however, were the most frequent barriers reported by pediatricians for prescribing controller asthma medication to children with public health insurance. The most frequent strategies used to provide controller asthma medication to these children were prescription of oral medications (59.5%) and giving away samples (44.7%). CONCLUSIONS: Current public health insurance policy in Puerto Rico creates a disincentive to the appropriate prescription of long term control medication for children with asthma. To improve the quality of asthma care of children in Puerto Rico, revision of this public health insurance policy is necessary.
与拥有私人保险的儿童相比,波多黎各拥有公共保险的儿童在哮喘长期控制药物的配药模式上存在显著差异。波多黎各的公共医疗保险政策将支付给初级保健医生和诊所的人头费中包含了药物费用。方法:除了一些未加入波多黎各医师学院的儿科医生(25名)外,向所有加入该学院的儿科医生(798名)邮寄调查问卷,共计823名儿科医生。其中,722名是符合条件的儿科医生,458名回复了调查,回复率为63.4%。结果:大多数受访者表示对国家哮喘教育和预防计划(NAEPP)指南(71.7%)以及NAEPP关于控制哮喘药物使用的建议(73.5%)有一定程度到非常熟悉。然而,用于支付哮喘药物的人头费不足(86.2%)和患者缺乏足够的医疗保险覆盖(83.2%)是儿科医生报告的为有公共医疗保险的儿童开具控制哮喘药物的最常见障碍。为这些儿童提供控制哮喘药物最常用的策略是开具口服药物(59.5%)和赠送样品(44.7%)。结论:波多黎各现行的公共医疗保险政策不利于为哮喘儿童适当开具长期控制药物。为提高波多黎各儿童哮喘护理的质量,有必要修订这一公共医疗保险政策。